MICHAEL SEAMON: Open Payments
NPI 1669747762 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 29 payments from 9 companies in 2025. Trend: 2023 $391 · 2024 $395 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $136 |
| Alnylam Pharmaceuticals Inc. | 6 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Abbott Laboratories | 2 | $52 |
| Philips North America LLC | 2 | $33 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| Boston Scientific Corporation | 1 | $33 |
| CVRx, Inc. | 1 | $21 |
| VivaQuant Inc, dba Rhythm Express | 1 | $9 |
Products named: LEQVIO, AMVUTTRA, CAMZYOS, Attruby, BodyGuardian, NAVITOR, CARDIOMEMS, Barostim Neo System.
Industry payments across AR — which companies pay providers there.
